The authors raised security concerns about this engineering strategy, as gain of function (GOF) mutations of the IL-7 receptor (CD127) are frequent in pediatric T cell acute lymphoblastic leukemia (T-ALL) and as CCR7 could play a role in tumor metastasis. Here, CCR7 is linked to acute lymphoblastic leukemia.